“The Buzz” Show: BioLineRX Ltd. (NASDAQ: BLRX) Announces Positive Phase 3 Trial Results | Financial Buzz

“The Buzz” Show: BioLineRX Ltd. (NASDAQ: BLRX) Announces Positive Phase 3 Trial Results

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “BioLineRX Ltd Announces Positive Phase 3 trial Results

BioLineRX Ltd (NASDAQ: BLRX) soared 68% higher in early morning trading from previous close after the company announced positive interim results from a Phase 3 trial of motixafortide. 

The company said an independent data monitoring committee analyzing the study’s primary endpoint saw “statistically significant evidence” favoring treatment with motixafortide for stem cell mobilization in multiple myeloma patients.

BioLineRx Ltd. is a late clinical-stage biopharmaceutical company focused on oncology. The Company’s business model is to in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development and/or commercialization.

For more information, please visit: BioLineRX Ltd. 

About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!